Cite
HARVARD Citation
Freckelton, J. et al. (2019). Body Composition Adjusted Dosing of Gemcitabine-Nab-Paclitaxel in Pancreatic Cancer Does Not Predict Toxicity Compared to Body Surface Area Dosing. Nutrition and cancer. pp. 624-628. [Online].